Skip to main content
. 2014 Aug 12;14:296. doi: 10.1186/1472-6882-14-296

Table 1.

Baseline demographic and clinical characteristics of the participants

Group 1 (n = 9) Group 2 (n = 9)
Sex (Men/Women) (5/4) (5/4)
Age (Mean ± SD) (years) 68.7 ± 3.1 70.3 ± 4.3
Disease duration (Mean ± SD) (years) 1.4 ± 0.6 1.3 ± 0.4
Duration of levodopa treatment (Mean ± SD) (years) 0.7 ± 0.3 0.8 ± 0.5